Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas

Archivum Immunologiae et Therapiae Experimentalis

Volumn 57, Issue 4, 2009, Pages 295-301

  Śliwińska Mossoń, Mariola ^a   Milnerowicz, Halina ^a   Rabczyński, Jerzy ^a   Milnerowicz, Stanisław ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Adenomocarcinoma; Immunochemistry; Metallothionein; P53 protein; Pancreas; Serous cystadenoma

Indexed keywords

ANTIBODY; EOSIN; HEMATOXYLIN; METALLOTHIONEIN; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTADENOMA; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CYST; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; ADENOCARCINOMA; COMPARATIVE STUDY; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PATHOPHYSIOLOGY;

ADENOCARCINOMA; ADULT; AGED; CYSTADENOMA, SEROUS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METALLOTHIONEIN; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349261345     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-009-0033-x     Document Type: Article

References (46)

1. AB Abdel-Mageed KC Agrawal 1998 Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response Cancer Res 58 2335 2338 9622069 1:CAS:528:DyaK1cXjs12ru7g%3D
2. W Alrefaie MH Katz DW Easter, et al. 2004 Simultaneous serous cystadenoma of the pancreas and mucinous cystadenoma of the appendix J Pancreas 5 97 100
3. D Bartsch D Bastian P Barth, et al. 1998 K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas Ann Surg 228 79 86 9671070 10.1097/00000658-199807000-00012 1:STN:280:DyaK1czjsVWntw%3D%3D (Pubitemid 30190319)
4. MG Cherian 1994 The significance of the nuclear and cytoplasmic tumor of metallothionein in human liver and tumor cells Environ Health Perspect 102 suppl 3 131 135 7843087 10.2307/3431776 1:CAS:528:DyaK2cXmvFyju7g%3D
5. MG Cherian MD Apostolova 2000 Nuclear localization of metallothionein during cell proliferation and differentiation. Cell Mol Biol 46 347 356 10774924 1:CAS:528:DC%2BD3cXisVais70%3D
6. CC Compton 2000 Serous cystic tumors of the pancreas. Semin Diagn Pathol 17 43 55 10721806 1:STN:280:DC%2BD3c7osVygsw%3D%3D
7. P Coyle JC Philcox LC Carey, et al. 2002 Metallothionein: the multipurpose protein Cell Mol Life Sci 59 627 647 12022471 10.1007/s00018-002- 8454-2 1:CAS:528:DC%2BD38XjtlWmtbs%3D (Pubitemid 34460681)
8. KG Danielson S Ohi PC Huang 1982 Immunochemical detection of metallothionein in specific epithelial cells of rat organs Proc Natl Asad Sci USA 79 2301 2304 10.1073/pnas.79.7.2301 1:CAS:528:DyaL38Xhslyms7o%3D (Pubitemid 12093259)
9. SR Davis RJ Cousins 2000 Metallothionein expression in animals: A physiological perspective on function J Nutr 130 1085 1088 10801901 1:CAS:528:DC%2BD3cXivFKnt7o%3D
10. MT del Vecchio L Pergola SA Tripodi, et al. 2002 Microcystic adenoma associated with a mucinous cystadenocarcinoma: a "collision tumor" of the pancreas Pancreas 24 106 108 11741191 10.1097/00006676-200201000-00015 (Pubitemid 34019667)
11. LZ Fan MG Cherian 2002 Potential role of p53 on metallothionein induction in human epithelial breast cancer cells Br J Cancer 87 1019 1026 12434295 10.1038/sj.bjc.6600549 1:CAS:528:DC%2BD38Xoslalu7Y%3D (Pubitemid 35305656)
12. B Gerdes A Wild J Wittenberg, et al. 2003 Tumor-suppressing pathways in cystic pancreatic tumors Pancreas 26 42 48 12499916 10.1097/00006676-200301000- 00008 1:CAS:528:DC%2BD3sXns1SntLw%3D (Pubitemid 36020265)
13. T. Hadama M. Kinoshita D Kobayashi, et al. 2002 Endogenous tumor necrosis factor promotes resistance to cellular stresses by inducing the metallothionein-1A gene Anticancer Res 22 4059 4063 12553033 1:CAS:528:DC%2BD3sXhtFGnu7w%3D
14. P Hainaut J Milner 1993 A structural role for metal ions in the "wide-type" conformation of the tumour suppressor protein p53 Cancer Res 53 1739 1742 8467489 1:CAS:528:DyaK3sXktVKjurg%3D
15. EE Ioachim AC Goussia NJ Agnantis, et al. 1999 Prognostic evaluation of metallothionein expression in human colorectal neoplasms J Clin Pathol 52 876 879 10711249 10.1136/jcp.52.12.876 1:STN:280:DC%2BD3c7ns1Gruw%3D%3D
16. T Ishikawa A Nakao S Nomoto, et al. 1998 Immunohistochemical and molecular biological studies of serous cystadenoma of the pancreas Pancreas 16 40 44 9436861 10.1097/00006676-199801000-00007 1:STN:280:DyaK1c%2Fpslelsw%3D%3D
17. AM Janssen W van Duijn FJ Kubben, et al. 2002 Prognostic significance of metallothionein in human gastrointestinal cancer. Clin Cancer Res 8 1889 1896 12060633 1:CAS:528:DC%2BD38Xlt1Crur0%3D
18. MG Joseph D Banerjee W Kocha, et al. 2001 Metallothionein expression in patients with small cell carcinoma of the lung Correlation with other molecular markers and clinical outcome. Cancer 92 836 842 1:CAS:528:DC%2BD3MXmvFKnsL8%3D
19. JH Kagi 1991 Overview of metallothionein Methods Enzymol 205 613 626 1779825 10.1016/0076-6879(91)05145-L 1:STN:280:DyaK387ktVWgtA%3D%3D
20. CD Klassen J Liu S Choudhuri 1999 Metallothionein: an intracellular protein to protect against cadmium toxicity Annu Rev Pharmacol Toxicol 39 267 294 10.1146/annurev.pharmtox.39.1.267 (Pubitemid 29222560)
21. Klöppel G, Solcia E, Longnecker DS et al (1996) Histological typing of tumours of the exocrine pancreas, second edition. Springer-Verlag, Berlin-Heidelberg-New York, pp 7-18
22. Y Kondo JM Rusnak DG Hoyt, et al. 1997 Enhanced apoptosis in metallothionein null cells Mol Pharmacol 52 195 201 9271341 1:CAS:528: DyaK2sXlvVeis78%3D
23. JA Madej H Milnerowicz S Dzimira 1999 Immunohistochemical localization of metallothionein (MT) in epithelial tumors in animals Med Wet 55 806 808
24. H Milnerowicz M Sliwinska-Mosson A Bizon, et al. 2006 Expression of metallothionein and p53 in pancreatic tumors in relation to prognosis Gut 55 A324
25. AG Montag N Fossati F Michelassi 1990 Pancreatic micro- cystic adenoma coexistent with pancreatic ductal carcinoma: a report of two cases Am J Surg Pathol 14 352 355 2157344 1:STN:280:DyaK3c3htVWgsg%3D%3D
26. R Nath R Kambadur S Gulati, et al. 1988 Molecular aspects, physiological, functions, and clinical significance of metallothioneins. Crit Rev Food Sci Nutr 27 41 85 3293923 1:CAS:528:DyaL1MXlsFWhtg%3D%3D
27. H Nitta M Hirota A Ohkado, et al. 2008 Coexistence of serous cystadenoma and ductal adenocarcinoma in the pancreas: a case report Pancreas 36 218 219 18376323 10.1097/01.MPA.0000311844.80924.9a
28. G Ohshio T Imamura N Okada, et al. 1996 Immunohistochemical study of metallothionein in pancreatic carcinomas. J Cancer Res Clin Oncol 122 351 355 8642045 10.1007/BF01220802 1:STN:280:DyaK283js1Ciug%3D%3D (Pubitemid 26168543)
29. T Oyama H Take T Hikino, et al. 1996 Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis Oncology 53 112 117 8604236 10.1159/000227546 1:STN:280:DyaK287otFOitw%3D%3D
30. NS Pellegata F Sessa B Renault, et al. 1994 K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions Cancer Res 54 1556 1560 8137263 1:CAS:528:DyaK2cXitFCjtb8%3D
31. B Perez-Ordonez A Nassem PH Lieberman, et al. 1996 Solid serous adenoma of the pancreas: the solid variant of serous cystadenoma Am J Surg Pathol 20 1401 1405 8898845 10.1097/00000478-199611000-00012 1:STN:280: DyaK2s%2FlsVGnug%3D%3D (Pubitemid 26367212)
32. G Pillai H Roberts K Gatter, et al. 2003 p53 expression in normal paraffin-embedded tissue using different antibodies and antigen retrieval buffer systems Histopathology 42 83 87 12493030 10.1046/j.1365-2559.2003.01563.x 1:STN:280:DC%2BD38jjtVKhsw%3D%3D (Pubitemid 36062572)
33. HV Posniak MC Olson TC Demos 1991 Coexistent adenocarcinoma and microcystic adenoma of the pancreas Clin Imaging 15 220 222 1933654 10.1016/0899-7071(91)90083-8 1:STN:280:DyaK38%2FjsVCgtw%3D%3D
34. J Rabczynski H Milnerowicz M Sliwinska-Mosson, et al. 2006 Hormone-producing serous cystadenoma of the pancreas Neoplasma 53 495 499 17167718 1:CAS:528:DC%2BD2sXhsVOlsb8%3D
35. Y Saga H Hashimoto S Yachiku, et al. 2002 Immunohistochemical expression of metallothionein in human bladder cancer: correlation with histopathological parameters and patient survival J Urol 168 2227 2231 12394764 10.1016/S0022-5347(05)64360-1 1:CAS:528:DC%2BD38XotFKrtro%3D
36. LD Santos C Chow CJ Henderson, et al. 2002 Serous oligocystic adenoma of the pancreas: a clinicopathological and immunohistochemical study of three cases with ultrastructural findings Pathology 34 148 156 12009097 10.1080/003130202760120508 (Pubitemid 34827996)
37. K Satoh T Shimosegawa S Moriizumi, et al. 1996 K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas Pancreas 12 362 368 8740403 10.1097/00006676-199605000-00007 1:STN:280:DyaK28zhtVClsw%3D%3D
38. KW Schmid IO Ellis JM Gee, et al. 1993 Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast Virchows Arch A Pathol Anat Histopathol 422 153 159 8385380 10.1007/BF01607167 1:STN:280:DyaK3s3itVamsw%3D%3D
39. D Schwartz V Rotter 1998 p53-dependent cell cycle control: response to genotoxic stress Semin Cancer Biol 8 325 336 10101798 10.1006/scbi.1998.0095 1:CAS:528:DyaK1MXitlSks7o%3D (Pubitemid 29131354)
40. O Strobel K Z'graggen FH Schmitz-Winnenthal, et al. 2003 Risk of malignancy in serous cystic neoplasms of the pancreas Digestion 68 24 33 12949436 10.1159/000073222 (Pubitemid 37256043)
41. H Symonds L Krall L Remington, et al. 1994 p53-dependent apoptosis suppresses tumor-growth and progression in-vivo Cell 78 703 711 8069917 10.1016/0092-8674(94)90534-7 1:CAS:528:DyaK2cXlslKnsLc%3D
42. A Tekada H Hisada S Okada, et al. 1997 Tumor cell growth is inhibited by suppressing metallothionein-I synthesis Cancer Lett 116 145 149 10.1016/S0304-3835(97)00172-9 (Pubitemid 27283001)
43. T Tomita 2000 Metallothionein in pancreatic endocrine neoplasms Mod Pathol 13 389 395 10786804 10.1038/modpathol.3880064 1:STN:280: DC%2BD3c3ks1CktA%3D%3D
44. T Tomita 2000 New markers for pancreatic islets and islet cell tumors Pathol Int 52 425 432 10.1046/j.1440-1827.2002.01368.x
45. B Zelger A Hittmair M Schir, et al. 1993 Immunohistochemically demonstrated metallothionein expression in malignant melanoma Histopathology 23 257 263 8225244 10.1111/j.1365-2559.1993.tb01198.x 1:STN:280: DyaK2c%2FktFahtw%3D%3D
46. J Zeng R Heuchel W Schaffner, et al. 1991 Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1 FEBS Lett 279 310 312 2001744 10.1016/0014-5793(91)80175-3 1:CAS:528:DyaK3MXhvVSntb0%3D